Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1927 of 5804
-
New daily adaptive radiation aims to cut side effects in prostate cancer patients
Symptom relief OngoingThis clinical trial evaluates the feasibility, safety, and tolerability of stereotactic ablative radiotherapy (SABR) using daily adaptive radiation techniques to the prostate fossa and/or pelvic lymph nodes in patients with prostate cancer who have undergone surgical removal of t…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New drug monitored for Crohn's relief in japan
Disease control Recruiting nowCrohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. This study will assess how safe and effective upadacitinib is in treating moderately to severely active CD in real world. Adverse events and change in disease activity will be assess…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Liver-Friendly lymphoma treatment? new drug dosing study offers hope
Disease control TerminatedThe primary objective of this study is to determine the recommended dosing regimen of loncastuximab tesirine in diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBCL) participants with moderate and severe hepatic impairment.
Phase: PHASE1 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Quizzing vs. Re-Study: which helps autistic kids learn words best?
Knowledge-focused Recruiting nowChildren on the autism spectrum sometimes have difficulty learning new words and using the newly taught information in different situations. In this study, the investigators are testing whether strategies that have been found to improve word learning in non-autistic children will…
Phase: NA • Sponsor: Louisiana State University and A&M College • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThe goal of the Lead-in phase of the study is to evaluate the safety, efficacy, pharmacokinetics (PK) and determine recommended dose for expansion (RDE) of NKT2152 in combination with palbociclib (Doublet) and with palbociclib and sasanlimab (Triplet) in subjects with advanced or…
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pill targets leukemia in early human trial
Disease control OngoingA Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-500, an oral FLT3 inhibitor, in adult patients with acute leukemia.
Phase: PHASE1 • Sponsor: Biomea Fusion Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sleep therapy may boost recovery success in substance use programs
Symptom relief CompletedThe goal of this clinical study is to learn whether treating sleep problems is helpful in people with substance abuse problems who are living in a residential treatment program. Another goal is to study whether treating sleep problems will help individuals stay in substance abuse…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New TB drug cocktails aim to cut treatment time in half
Disease control TerminatedThis multicenter, two-stage, open-label, randomized trial will aim to assess the efficacy, safety, optimal duration, and pharmacokinetics (PK) of Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS) and Pretomanid, Bedaquiline, OPC-167832, and Sutezolid (PBOS) in adult partic…
Phase: PHASE2 • Sponsor: Gates Medical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can smarter outreach help more smokers kick the habit?
Disease control CompletedThe purpose of this research study is to see if offering adult primary care patients who smoke combustible cigarettes more frequent outreach, more choices about how they receive that outreach, and more smoking treatment options will increase the use of smoking treatments and help…
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New MRI dye could mean less gadolinium for patients
Diagnosis CompletedResearchers are looking for a better way to help people with any known or suspected problems (except brain or spinal cord-related problems) scheduled for a "contrast-enhanced" Magnetic Resonance Imaging (MRI). MRI is used by doctors to create detailed images of the inside of the…
Phase: PHASE3 • Sponsor: Bayer • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Gut gene may reveal Who's at risk from red meat
Knowledge-focused OngoingThe risk of cardiovascular diseases from red meat consumption varies among individuals due to variations in gut microbiota. L-carnitine in red meat can be converted to TMAO in the body by certain bacteria. Not everyone experiences a significant increase in TMAO levels after consu…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Could a quick ultrasound replace CT scans for Kids' skull fractures?
Diagnosis CompletedThis study aims to evaluate the accuracy of POCUS as a screening tool for early diagnosis of skull fractures in children with mild closed head injuries admitted to the emergency department. The results would aid the emergency physicians to speed up the management and reduce the c…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Wrist vs groin: which artery route is best for stroke clot removal?
Disease control Recruiting nowStroke is one of the most important diseases endangering the health and quality of life of Chinese people. Acute ischemic stroke (AIS) is commonly caused by cerebrovascular stenosis or occlusion. The most effective treatment for AIS is timely and successful angiographic reperfusi…
Phase: NA • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New gel shows promise for diabetic foot wounds
Disease control CompletedThis is a phase 2 study performed in diabetic foot ulcer (DFU) patients with chronic non-healing, neuro-ischemic wounds to investigate the safety, tolerability and efficacy of AUP1602-C.
Phase: PHASE2 • Sponsor: Aurealis Oy • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Spinal stimulation and training: a new hope for movement after injury?
Knowledge-focused Recruiting nowThis study will help the investigators better understand the changes in short-term excitability and long-term plasticity of corticospinal, reticulospinal and spinal neural circuits and how the changes impact the improvements of spinal cord stimulation (SCS) mediated motor functio…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Smart app aims to optimize heart failure meds
Disease control CompletedThe SmartHF study is a 12-week prospective randomized controlled multicenter clinical trial. This study will investigate the efficacy of an adaptive web application to facilitate guideline-directed medical therapy (GDMT) optimization in HFrEF patients. Eligible participants will …
Phase: PHASE3 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
MCT8 deficiency drug withdrawal trial raises questions about lifelong treatment
Disease control CompletedThis is a double-blind, randomized phase 3 multicenter placebo-controlled study in at least 16 evaluable male participants diagnosed with MCT8 deficiency. Male participants, from 4 years of age (at randomization) and having demonstrated stable maintenance treatment with tiratrico…
Phase: PHASE3 • Sponsor: Rare Thyroid Therapeutics International AB • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Exercise program shows promise for Diabetes-Related memory problems
Disease control CompletedA 12-week Intensive Aerobic and Resistance Exercise Program (IAREP) intervention was implemented on high-risk and low-risk subjects with cognitive impairment in type 2 Diabetes Mellitus. The study aims to evaluate the effectiveness of IAREP on cognition, metabolic and inflammator…
Phase: NA • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug shows promise in shrinking breast cancer tumors before surgery
Disease control CompletedThis study is a window of opportunity clinical trial to evaluate the efficacy of giredestrant (GDC-9545) or tamoxifen in estrogen receptor-positive (ER\[+\])/human epidermal growth factor receptor 2-negative (HER2\[-\]) primary invasive adenocarcinoma of the breast with Ki67 leve…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Your phone might spot Alzheimer's early
Diagnosis OngoingThis study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC